Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.
Latest Ratings for PFE
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Wells FargoMaintainsOverweight Jan 2022B of A SecuritiesUpgradesNeutralBuy